Cyclacel Pharmaceuticals, Inc. (CYCC) Narrows Q2 Loss

August 14, 2013 4:52 PM

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) reported Q2 EPS of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found